Clinical Trial Update: Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

View source ↗

Summary

Boehringer Ingelheim completed a study to develop a screening tool for detecting interstitial lung disease in people with rheumatoid arthritis, using various ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Rheumatoid Arthritis

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid, Lung Diseases, Interstitial | Status: COMPLETED